Literature DB >> 23345935

History, ethics, advantages and limitations of experimental models for hepatic ablation.

Seok Ling Ong, Gianpiero Gravante, Matthew S Metcalfe, Ashley R Dennison.   

Abstract

Numerous techniques developed in medicine require careful evaluation to determine their indications, limitations and potential side effects prior to their clinical use. At present this generally involves the use of animal models which is undesirable from an ethical standpoint, requires complex and time-consuming authorization, and is very expensive. This process is exemplified in the development of hepatic ablation techniques, starting experiments on explanted livers and progressing to safety and efficacy studies in living animals prior to clinical studies. The two main approaches used are ex vivo isolated non-perfused liver models and in vivo animal models. Ex vivo non perfused models are less expensive, easier to obtain but not suitable to study the heat sink effect or experiments requiring several hours. In vivo animal models closely resemble clinical subjects but often are expensive and have small sample sizes due to ethical guidelines. Isolated perfused ex vivo liver models have been used to study drug toxicity, liver failure, organ transplantation and hepatic ablation and combine advantages of both previous models.

Entities:  

Keywords:  Ablation; Ex vivo; Experiment; In vivo; Liver; Perfusion

Mesh:

Year:  2013        PMID: 23345935      PMCID: PMC3547565          DOI: 10.3748/wjg.v19.i2.147

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  51 in total

1.  Cytokine response of electrolytic ablation in an ex vivo perfused liver model.

Authors:  Gianpiero Gravante; Seok Ling Ong; Matthew S Metcalfe; Roberto Sorge; John Overton; David M Lloyd; Guy J Maddern; Ashley R Dennison
Journal:  ANZ J Surg       Date:  2010 Jul-Aug       Impact factor: 1.872

Review 2.  Electrodes and multiple electrode systems for radiofrequency ablation: a proposal for updated terminology.

Authors:  Stefaan Mulier; Yi Miao; Peter Mulier; Benoit Dupas; Philippe Pereira; Thierry de Baere; Riccardo Lencioni; Raymond Leveillee; Guy Marchal; Luc Michel; Yicheng Ni
Journal:  Eur Radiol       Date:  2005-02-12       Impact factor: 5.315

3.  Selective effects of nitric oxide on the disposition of chlorzoxazone and dextromethorphan in isolated perfused rat livers.

Authors:  Ragini Vuppugalla; Reza Mehvar
Journal:  Drug Metab Dispos       Date:  2006-04-18       Impact factor: 3.922

4.  Microwave ablation in a hepatic porcine model: correlation of CT and histopathologic findings.

Authors:  Michael M Awad; Lara Devgan; Ihab R Kamel; Michael Torbensen; Michael A Choti
Journal:  HPB (Oxford)       Date:  2007       Impact factor: 3.647

5.  Experimental and clinical radiofrequency ablation: proposal for standardized description of coagulation size and geometry.

Authors:  Stefaan Mulier; Yicheng Ni; Lars Frich; Fernando Burdio; Alban L Denys; Jean-François De Wispelaere; Benoît Dupas; Nagy Habib; Michael Hoey; Maarten C Jansen; Marc Lacrosse; Raymond Leveillee; Yi Miao; Peter Mulier; Didier Mutter; Kelvin K Ng; Roberto Santambrogio; Dirk Stippel; Katsuyoshi Tamaki; Thomas M van Gulik; Guy Marchal; Luc Michel
Journal:  Ann Surg Oncol       Date:  2007-01-24       Impact factor: 5.344

6.  Disposition kinetics of propranolol isomers in the perfused rat liver.

Authors:  Daniel Y Hung; Gerhard A Siebert; Ping Chang; Yuri G Anissimov; Michael S Roberts
Journal:  J Pharmacol Exp Ther       Date:  2004-06-10       Impact factor: 4.030

7.  Artificial surface-induced cytokine synthesis: effect of heparin coating and complement inhibition.

Authors:  Knut Tore Lappegård; Michael Fung; Grethe Bergseth; Johan Riesenfeld; Tom Eirik Mollnes
Journal:  Ann Thorac Surg       Date:  2004-07       Impact factor: 4.330

8.  Acute hepatic coma successfully treated by extracorporeal baboon liver perfusions.

Authors:  G M Abouna; L M Fisher; W J Still; D M Hume
Journal:  Br Med J       Date:  1972-01-01

Review 9.  Local ablation for unresectable liver tumors: is thermal best?

Authors:  Simon A Wemyss-Holden; Ashley R Dennison; David P Berry; Guy J Maddern
Journal:  J Hepatobiliary Pancreat Surg       Date:  2004

Review 10.  Systematic review of randomized trials for hepatocellular carcinoma treated with percutaneous ablation therapies.

Authors:  Yun Ku Cho; Jae Kyun Kim; Mi Young Kim; Hyunchul Rhim; Joon Koo Han
Journal:  Hepatology       Date:  2009-02       Impact factor: 17.425

View more
  3 in total

1.  Integrated bioinformatics analysis to identify 15 hub genes in breast cancer.

Authors:  Haoxuan Jin; Xiaoyan Huang; Kang Shao; Guibo Li; Jian Wang; Huanming Yang; Yong Hou
Journal:  Oncol Lett       Date:  2019-05-30       Impact factor: 2.967

2.  Radiological findings of porcine liver after electrochemotherapy with bleomycin.

Authors:  Maja Brloznik; Nina Boc; Gregor Sersa; Jan Zmuc; Gorana Gasljevic; Alenka Seliskar; Rok Dezman; Ibrahim Edhemovic; Nina Milevoj; Tanja Plavec; Vladimira Erjavec; Darja Pavlin; Masa Bosnjak; Erik Brecelj; Ursa Lampreht Tratar; Bor Kos; Jani Izlakar; Marina Stukelj; Damijan Miklavcic; Maja Cemazar
Journal:  Radiol Oncol       Date:  2019-10-10       Impact factor: 2.991

3.  Why scientists perform animal experiments, scientific or personal aim?

Authors:  Burhan Mayir; Uğur Doğan; Tuna Bilecik; Erdem Can Yardımcı; Tuğrul Çakır; Arif Aslaner; Yeliz Akpınar Mayir; Mehmet Tahir Oruç
Journal:  Ulus Cerrahi Derg       Date:  2016-10-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.